NewTimeSpace (newtimespace.com) reported that on July 28, 2026, the robotics theme weakened, while Midea Group (00300.HK) fluctuated slightly higher. As of 13:11, the stock was quoted at HKD 95.600, up 0.79%.
NewTimeSpace News: Lepu Biopharma Co., Ltd. (02157.HK) announced positive top-line results from CLARITY-GASTRIC01, the global Phase III clinical trial of CMG901 (sonesitatug vedotin, AZD0901), an ADC candidate co-developed with AstraZeneca. Compared with investigator’s choice of treatment, the candidate delivered statistically significant and clinically meaningful improvement in overall survival among patients with CLDN18.2-positive advanced gastric cancer receiving second-line and later-line therapy. Its safety profile remained consistent with known data and no new safety signals were identified.
NewTimeSpace News: Unisound announced on 28 July that the Company has fully completed capability upgrades for U2-ASR and U2-TTS, expanding its voice large model coverage from "hundreds of Chinese dialects" to "global multilingual support".
NewTimeSpace News: Hengrui Pharmaceuticals disclosed in an announcement dated July 27 that SHR-4375 Injection, an in-house TF-targeted ADC drug developed by the Company, has received Orphan Drug Designation from the U.S. FDA for the indication of pancreatic cancer treatment.
NewTimeSpace News: Kaisa Health announced on 27 July that Hydromorphone Hydrochloride Injection (specification: 1ml:2mg) produced by Qinghai Pharmaceutical, a subsidiary of the Group, has been granted a Drug Registration Certificate issued by the National Medical Products Administration (NMPA), with approval for domestic production registration.
NewTimeSpace News: Hengrui Pharmaceuticals announced on July 27 that its subsidiary Shandong Shengdi received the Drug Clinical Trial Approval Notice for HRS-1780 Tablets issued by the National Medical Products Administration (NMPA), granting approval for Phase II/III clinical trials to treat uncontrolled hypertension or resistant hypertension.
NewTimeSpace News: Broncus Holding announced that its BroncTru® disposable bronchoscopic dilation catheter has obtained EU MDR CE certification, marking significant progress in the company's international registration and global product deployment. The product has already secured approvals from NMPA, FDA, and EU CE, and is cleared for sale in Taiwan, Indonesia, Thailand, and Malaysia.
NewTimeSpace News: InnoCare Pharma Limited (09969.HK) announced that the pivotal Phase III registration trial of fadeucravacitinib (ICP-488), a potent and highly selective TYK2 allosteric inhibitor, for patients with moderate to severe plaque psoriasis has successfully met the statistically significant primary endpoint and delivered clinically meaningful improvements. The safety profile is consistent with previous studies with no new safety signals identified.
On July 27, 2026, Hong Kong stocks closed higher with the Hang Seng Index up 0.98%, driven by rallies in Foundation Models and Embodied AI. MINIMAX-W surged 17.14% following a bullish Goldman Sachs rating, while XIAOMI-W jumped 7.34% on new EV model announcements and stock buybacks. Key industry catalysts include domestic DRAM leader Changxin Technology surging over 470% on its STAR Market IPO debut, Hong Kong’s upcoming Embodied AI listings in late August, and strong endorsements of Chinese AI from Jensen Huang and Elon Musk.
NewTimeSpace News: On 27 July 2026, XPENG-W(09868.HK) traded slightly weaker in the afternoon. As of 14:33, the stock quoted HK$49.12, down 0.73%. Xpeng recently announced it will roll out five brand-new vehicle models in the second half of 2026 and launch advanced intelligent driving assistance systems in Australia in 2027.
NewTimeSpace (newtimespace.com) reported that on July 27, 2026, the semiconductor theme in Hong Kong stocks weakened, with ASMPT (00522.HK) fluctuating lower. As of 13:21, the stock was quoted at HKD 156.100, down 4.47%.
NewTimeSpace (newtimespace.com) reported that on July 27, 2026, the robotics theme rose in volatile trading, with Xiaomi-W (01810.HK) surging sharply. As of 13:10, the stock was quoted at HKD 28.900, up 8.16%.
NewTimeSpace News: JIANGXI BIOLOGYannounced on 27 July that the veterinary tetanus antitoxin production line of its wholly-owned subsidiary Chifeng Boen Pharmaceutical Co., Ltd. was officially commissioned in Chifeng, Inner Mongolia on 20 July 2026.
NewTimeSpace News: Jacobio Pharmaceuticals announced on July 27 that the Phase IIa clinical trial of its self-developed BET inhibitor JAB-8263 for rheumatoid arthritis has completed the first patient dosing in China.
On July 24, 2026, Hong Kong stocks closed lower led by Big Tech, while AI chipmakers and LLM developers bucked the trend, with MONTAGETECH surging 6.7% and Z.AI up 5.64%. Beijing unveiled policies supporting the Token Economy and inference chips, as Dongguan launched a RMB 100-billion computing power plan. Meanwhile, Agibot initiated its HK IPO, and Tesla's sharp drop weighed on autonomous driving sentiment.
NewTimeSpace News: Lens Technology (6613.HK) announced on July 24 that its wholly-owned subsidiary Lens International recently signed a cooperation MOU with Intel Corporation, with TGV advanced packaging as the key discussion direction. The Parties will discuss and evaluate potential cooperation on key processes including glass substrate via formation, high-precision laser processing, metallized via deposition, and multi-layer interconnect routing, and will also explore cooperation opportunities in AI PC structural components, data center server components, and embodied intelligent robots. Most provisions of the MOU are not legally binding, and whether subsequent formal agreements can be signed involves significant uncertainty. As of the announcement date, the TGV advanced packaging business has not had a material impact on operating performance.
